Article
Identification of a loss-of-function inducible degrader of the low-density lipoprotein receptor variant in individuals with low circulating low-density lipoprotein.
European heart journal - 1 May 2013
Sorrentino Vincenzo, Fouchier Sigrid W, Motazacker Mohammad M, Nelson Jessica K, Defesche Joep C, Dallinga-Thie Geesje M, Kastelein John J P, Kees Hovingh G, Zelcer Noam
Abstract excerpt
AIMS: Recent genome-wide association studies suggest that IDOL (also known as MYLIP) contributes to variation in circulating levels of low-density lipoprotein cholesterol (LDL-C). IDOL, an E3-ubiquitin ligase, is a recently identified post-transcriptional regulator of LDLR abundance. Briefly, IDOL promotes degradation of the LDLR thereby limiting LDL uptake. Yet the exact role of IDOL in human lipoprotein...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
